{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:08:57Z","timestamp":1790014137523,"version":"4.0.1"},"reference-count":13,"publisher":"Weston Medical Publishing","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Opioid Management"],"abstract":"<jats:p>Design: Retrospective observational study.Setting: Seven intensive care units (ICUs) across the MaineHealth system.Patients: Adults with opioid use disorder (OUD) admitted to the ICU between November 2023 and June 2025.Intervention: None.Measures: Receipt of medications for OUD (M-OUD) assessed preadmission, during hospitalization (ICU and general ward), and at discharge, stratified by prior treatment status and hospital rurality.Results: Among 1,113 patients, 15.6 percent were on M-OUD preadmission. M-OUD exposure increased during ICU care, with no significant difference between urban and rural patients (44 percent vs 39 percent, p = 0.134). On the general ward, M-OUD exposure decreased: 29.8 percent of previously untreated patients received M-OUD, while 57.2 percent of those on preadmission M-OUD did not receive therapy (p &lt; 0.001). At discharge, M-OUD prescribing was significantly lower in rural versus urban patients (8 percent vs 22 percent, p &lt; 0.001).Conclusion: M-OUD remains underutilized across the ICU care continuum, with loss of treatment continuity at discharge for rural and urban patients.<\/jats:p>","DOI":"10.5055\/jom.1003","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:27:22Z","timestamp":1790011642000},"page":"369-373","source":"Crossref","is-referenced-by-count":0,"title":["Medications for opioid use disorder receipt in intensive care patients with opioid use disorder\u2014A statewide cohort study"],"prefix":"10.5055","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7573-2164","authenticated-orcid":false,"given":"Aurora N.","family":"Quaye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5903-8769","authenticated-orcid":false,"given":"Leo K.","family":"Westgard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2825-6134","authenticated-orcid":false,"given":"Janelle M.","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8255-8387","authenticated-orcid":false,"given":"Alysse G.","family":"Wurcel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3008","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"105574","unstructured":"Ahmad FBCJ, Rossen LM, Sutton P: Provisional drug overdose death counts. National Center for Health Statistics. 2023. Available at https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdosedata.htm. Accessed July 3, 2023."},{"key":"105575","doi-asserted-by":"crossref","unstructured":"Moran BL, Myburgh JA, Scott DA: The complications of opioid use during and post-intensive care admission: A narrative review. Anaesth Intensive Care. 2022; 50(1-2): 108-126. DOI: 10.1177\/0310057x211070008.","DOI":"10.1177\/0310057X211070008"},{"key":"105576","doi-asserted-by":"crossref","unstructured":"Stevens JP, Wall MJ, Novack L, et al.: The critical care crisis of opioid overdoses in the United States. Ann Am Thorac Soc. 2017; 14(12): 1803-1809. DOI: 10.1513\/AnnalsATS.201701-022OC.","DOI":"10.1513\/AnnalsATS.201701-022OC"},{"key":"105577","doi-asserted-by":"crossref","unstructured":"Karamchandani K, Carr ZJ, Bonavia A, et al.: Critical care pain management in patients affected by the opioid epidemic: A review. Ann Am Thorac Soc. 2018; 15(9): 1016-1023. DOI: 10.1513\/AnnalsATS.201801-028FR.","DOI":"10.1513\/AnnalsATS.201801-028CME"},{"key":"105578","doi-asserted-by":"crossref","unstructured":"Markus H, Ceneviva GD, Thomas NJ, et al.: Impact of substance use disorders on critical care management and health outcomes in septic adolescents. Ann Intensive Care. 2025; 15(1): 63. DOI: 10.1186\/s13613-025-01482-8.","DOI":"10.1186\/s13613-025-01482-8"},{"key":"105579","doi-asserted-by":"crossref","unstructured":"Sordo L, Barrio G, Bravo MJ, et al.: Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies. BMJ. 2017; 357: j1550. DOI: 10.1136\/bmj.j1550.","DOI":"10.1136\/bmj.j1550"},{"key":"105580","doi-asserted-by":"crossref","unstructured":"Wakeman SE, Larochelle MR, Ameli O, et al.: Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Netw Open. 2020; 3(2): e1920622. DOI: 10.1001\/jamanetworkopen.2019.20622.","DOI":"10.1001\/jamanetworkopen.2019.20622"},{"key":"105581","doi-asserted-by":"crossref","unstructured":"Feeney ME, Law AC, Walkey AJ, et al.: Variation in use of medications for opioid use disorder in critically ill patients across the United States. Crit Care Med. 2024; 52(7): e365-e375. DOI: 10.1097\/ccm.0000000000006257.","DOI":"10.1097\/CCM.0000000000006257"},{"key":"105582","doi-asserted-by":"crossref","unstructured":"Erstad BL, Glenn MJ: Considerations and limitations of buprenorphine prescribing for opioid use disorder in the intensive care unit setting: A narrative review. Am J Health Syst Pharm. 2024; 81(6): 171-182. DOI: 10.1093\/ajhp\/zxad289.","DOI":"10.1093\/ajhp\/zxad289"},{"key":"105583","doi-asserted-by":"crossref","unstructured":"Quaye A, Wampole C, Riker RR, et al.: Buprenorphine continuation during critical illness associated with decreased inpatient opioid use in individuals maintained on buprenorphine for opioid use disorder in a retrospective study. J Clin Pharmacol. 2023; DOI: 10.1002\/jcph.2286.","DOI":"10.1002\/jcph.2286"},{"key":"105584","doi-asserted-by":"crossref","unstructured":"Haffajee RL, Lin LA, Bohnert ASB, et al.: Characteristics of US counties with high opioid overdose mortality and low capacity to deliver medications for opioid use disorder. JAMA Network Open. 2019; 2(6): e196373-e196373. DOI: 10.1001\/jamanetworkopen.2019.6373.","DOI":"10.1001\/jamanetworkopen.2019.6373"},{"key":"105585","doi-asserted-by":"crossref","unstructured":"Weiner SG, Little K, Yoo J, et al.: Opioid overdose after medication for opioid use disorder initiation following hospitalization or ED visit. JAMA Netw Open. 2024; 7(7): e2423954. DOI: 10.1001\/jamanetworkopen.2024.23954.","DOI":"10.1001\/jamanetworkopen.2024.23954"},{"key":"105586","doi-asserted-by":"crossref","unstructured":"Reichheld AM, Hills-Evans K, Sheehan JK, et al.: A national survey of approaches to manage the ICU patient with opioid use disorder. J Crit Care. 2019; 54: 42-47. DOI: 10.1016\/j.jcrc.2019.06.032.","DOI":"10.1016\/j.jcrc.2019.06.032"}],"container-title":["Journal of Opioid Management"],"original-title":[],"link":[{"URL":"https:\/\/wmpllc.org\/ojs\/index.php\/jom\/article\/download\/4140\/4417","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/wmpllc.org\/ojs\/index.php\/jom\/article\/download\/4140\/4417","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:27:28Z","timestamp":1790011648000},"score":1,"resource":{"primary":{"URL":"https:\/\/wmpllc.org\/ojs\/index.php\/jom\/article\/view\/4140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":13,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,9,21]]}},"URL":"https:\/\/doi.org\/10.5055\/jom.1003","relation":{},"ISSN":["1551-7489","1551-7489"],"issn-type":[{"value":"1551-7489","type":"electronic"},{"value":"1551-7489","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}